Curation FAME2 STARD7

Gene STARD7
Disease FAME2
Inheritance AD
Score

12 + 0 = 12 / 18

Genetic + experimental = total
Classification
0
18
Refuted
Moderate
Definitive
Last Updated 08/14/2025
Pubs Reviewed 1
Publication Span
Publication Interval
Curator(s) Macayla Weiner, Laurel Hiatt
Description

FAME2 is caused by an intronic ATTTC pentanucleotide repeat expansion in the first intron of STARD7. Corbett et al. identified ATTTT/ATTTC repeat expansions in the chromosome 2 FAME interval using WGS-based ExpansionHunter/exSTRa analysis and validated the STARD7 ATTTC expansion by repeat-primed PCR. The expansion segregated with FAME in 158 affected individuals from 22 pedigrees and was absent from tested controls; anticipation was observed in a large family, while STARD7 mRNA and protein abundance were not altered in available patient-derived fibroblasts, supporting a repeat-sequence mechanism rather than STARD7 loss of expression.

Genetic evidence

Total: 12

Category
Type
Citation
Score
Details
Singular Evidence
Probands
6

Twenty-two FAME2 pedigrees were investigated; 158 affected individuals tested positive for the intronic STARD7 ATTTC expansion by RP-PCR, including 137/137 affected individuals from 16 previously reported chromosome 2-linked families and 20/20 familial clinically similar cases.

Collective Evidence
Allele
1

Long-read sequencing resolved expanded STARD7 repeat structures in affected individuals, including combined AAATG/AAAAT insertions of ~3.3–4.6 kb, and Family 1 showed anticipation with median onset decreasing from generation III (30 years) to IV (17 years) to V (12 years).

Collective Evidence
Computational
0.5

Short-read WGS analysis with ExpansionHunter and exSTRa identified ATTTT/ATTTC repeat expansions in the FAME2 interval in affected samples; all FAME2 carriers were significant exSTRa outliers at the FAME2-AAATG locus (p < 0.0001) compared with 69 unaffected WGS controls.

Collective Evidence
Segregation
1.5

RP-PCR showed the STARD7 ATTTC expansion segregated with FAME in 158/158 affected individuals across 22 families; 24 unaffected relatives were negative, and two expansion-positive individuals without a FAME diagnosis were from younger generations and considered likely presymptomatic.

Statistics
Case-control data
6

The ATTTC repeat was absent from WGS data for 69 controls and did not amplify in 28 unaffected unrelated control DNA samples; among family testing, 158 affected individuals were expansion-positive and no affected individuals were expansion-negative.

Experimental evidence

Total: 0

No experimental evidence details available.

Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.